HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Levetiracetam for benign epilepsy of childhood with centrotemporal spikes-three cases.

Abstract
Benign epilepsy with centrotemporal spikes (BECTS), also known as benign rolandic epilepsy (BRE) of childhood represents 15% of all childhood epilepsies [Handbook of Epilepsy Treatment (2000)]. A majority of these patients do no require treatment; however, in those cases where treatment is justified, the most efficacious medication with a benign safety profile should be selected. We present three clinical cases of otherwise healthy children with BECTS who were treated only with levetiracetam. All three of these children remain seizure-free and are experiencing no reported side effects.
AuthorsLuis E Bello-Espinosa, Summer L Roberts
JournalSeizure (Seizure) Vol. 12 Issue 3 Pg. 157-9 (Apr 2003) ISSN: 1059-1311 [Print] England
PMID12651081 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anticonvulsants
  • Levetiracetam
  • Piracetam
Topics
  • Anticonvulsants (administration & dosage, therapeutic use)
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Epilepsy, Rolandic (drug therapy)
  • Female
  • Humans
  • Levetiracetam
  • Neurologic Examination
  • Piracetam (administration & dosage, analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: